Prescribe Prelivia to increase circulation and perfusion in the area of risk for Pressure Injuries
More than 2.5 million people in the United States suffer from pressure injuries (PIs) and one in 40 of these people die. Prelivia, our proprietary neurostimulation technology, has been shown to reduce pressure ulcers (bed sores) by continuously promoting healthy blood circulation and tissue oxygenation in people who are bedridden or chair bound. Prelivia IES-1 has been cleared by the U.S. Food and Drug Administration, enabling clinical testing in healthcare facilities. Contact us about our Free 90-Day Quality Improvement Trial for your hospital or care home today.